Takeda Pharmaceutical Company Limited Stock Performance
as on October 30, 2025 at 1:29 am IST
Day's Low
Day's High
$13.74$13.94
0.15%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
$12.8$15.696.98%
Downside
14.03%
Upside
Takeda Pharmaceutical Company Limited share price movements today
- Previous Close
- $14.10
- Open
- $13.88
- Volume
- 3.1M
- Day's Low - High
- $13.74 - $13.94
- 52 Week Low - High
- $12.8 - $15.69
Takeda Pharmaceutical Company Limited Historical Returns
- 1 Month Return
- -3.56 %
- 3 Month Return
- -1.54 %
- 1 Year Return
- + 1.81 %
- 3 Year Return
- + 6.82 %
- 5 Year Return
- -11.6 %
Takeda Pharmaceutical Company Limited Stock Fundamentals & Key Indicators
Check Takeda Pharmaceutical Company Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$44.8B
EPS (TTM)
0Dividend Yield
4.05%
Quarterly Earnings Growth YOY
0.30%
PE Ratio (TTM)
50.61
Industry PE ratio
19.200384615384614
PEG Ratio
0.4185
EBITDA
1.2T
Revenue (TTM)
4.5T
Profit Margin
3.06%
Return On Equity TTM
1.87%
Takeda Pharmaceutical Company Limited Stock Valuation
Track how Takeda Pharmaceutical Company Limited P/E has moved over time to understand its valuation trends.
Takeda Pharmaceutical Company Limited in the last 5 years
Lowest (0.08x)
June 30, 2025
Industry (19.20x)
October 29, 2025
Today (50.61x)
October 29, 2025
Highest (1.14x)
September 30, 2023
Today’s Price to Earnings Ratio: 50.61x
Takeda Pharmaceutical Company Limited vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Takeda Pharmaceutical Company Limited with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $44.8B | -11.6% | 50.61 | 3.06% | |
| BUY | $18.8B | NA | 16.2 | 40.36% | |
| BUY | $41.6B | NA | 20.91 | 13.81% | |
| BUY | $14.6B | 48.99% | 43.6 | 13.88% | |
| BUY | $65.4B | -9.79% | 25.13 | 27.83% |
Stock Returns calculator for Takeda Pharmaceutical Company Limited Stock including INR - Dollar returns
The Takeda Pharmaceutical Company Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Takeda Pharmaceutical Company Limited investment value today
Current value as on today
₹1,04,412
Returns
₹4,412
(+4.41%)
Returns from Takeda Pharmaceutical Company Limited Stock
Dollar Returns*
₹5,061 (+5.06%)
Analyst Recommendation on Takeda Pharmaceutical Company Limited Stock
Based on 23 analysts
52.17%
Buy
47.83%
Hold
0.00%
Sell
Based on 23 analysts, 52.17% of analysts recommend a 'BUY' rating for Takeda Pharmaceutical Company Limited. Average target price of $17.85
Takeda Pharmaceutical Company Limited Share Price Target
Get share price movements and forecasts by analysts on Takeda Pharmaceutical Company Limited.
What analysts predicted
22.91%UPSIDE
Target Price
$17.85
Current Price
$13.76
Analyzed by
23 Analysts
Target
$17.85
Takeda Pharmaceutical Company Limited target price $17.85, a slight upside of 22.91% compared to current price of $13.76. According to 23 analysts rating.
Takeda Pharmaceutical Company Limited Stock’s Investor Sentiment and Interest
Search interest for Takeda Pharmaceutical Company Limited Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:11% versus previous 30 day period
Takeda Pharmaceutical Company Limited Quarterly Profit & Loss
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Annual Profit & Loss
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Quarterly Cash Flow
All numbers in Millions USD
Takeda Pharmaceutical Company Limited Annual Cash Flow
All numbers in Millions USD
Takeda Pharmaceutical Company Limited News & Key Events
Today's Timeline - 21 October
Tue, 03:23 PM
-Takeda signs research partnership with Nabla Bio to enhance AI-driven drug delivery and design protein-based treatments.
Wed, 05:55 AM
-Takeda partners with Innovent Biologics to co-develop and commercialize late-stage oncology medicines globally, excluding Greater China and the U.S.
Insights on Takeda Pharmaceutical Company Limited
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Takeda Pharmaceutical Company Limited has shown positive profit trends over the last two quarters. Their net profit increased from -103.2 billion to 124.24 billion dollars, representing an average increase of 183.1% per quarter.
- POSITIVE IMPACT
Revenue Rich
Takeda Pharmaceutical Company Limited has shown positive revenue growth over the last two quarters. Revenue increased from $1,053.4 billion to $1,106.68 billion, reflecting an average growth of 4.8% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation has given 27.5% return, outperforming this stock by 20.7%
- NO EFFECT
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 26.8% return, outperforming this stock by 25.0%
NEGATIVE IMPACTPrice Dip
In the last 6 months, TAK stock has moved down by -7.7%
About Takeda Pharmaceutical Company Limited
| Organisation | Takeda Pharmaceutical Company Limited |
| Headquarters | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
| Industry | Health Technology |
| CEO | Mr. Christophe Weber |
| E-voting on shares | Click here to vote |
Key Management of Takeda Pharmaceutical Company Limited
Name | Title |
|---|---|
Mr. Milano Furuta | CFO & Director |
Norimasa Takeda | Chief Accounting Officer & Corporate Controller |
Mr. Iwaaki Taniguchi | Senior Vice President of Corporate Finance & Controlling Department |
Mr. Christophe Weber | President, CEO & Representative Director |
Dr. Andrew S. Plump M.D., Ph.D. | President of Research & Development and Representative Director |
Dr. Seigo Izumo | Chair of Management Board |
Mr. Haruhiko Hirate | Member of Management Board |
Mr. Salvatore Alesci M.D., Ph.D. | Member of Management Board and Head of R&D Global Science & Biomedical Policy |
Mr. Gabriele Ricci | Chief Data & Technology Officer |
Mr. Christopher David O'Reilly | Global Head of Investor Relations & Global Finance |
FAQs
What is Takeda Pharmaceutical Company Limited share price today?
Takeda Pharmaceutical Company Limited share price today is $13.76 as on at the close of the market. Takeda Pharmaceutical Company Limited share today touched a day high of $13.94 and a low of $13.74.
What is the 52 week high and 52 week low for Takeda Pharmaceutical Company Limited share?
Takeda Pharmaceutical Company Limited share touched a 52 week high of $15.69 on and a 52 week low of $12.8 on . Takeda Pharmaceutical Company Limited stock price today i.e. is closed at $13.76,which is 12.30% down from its 52 week high and 7.50% up from its 52 week low.
What is Takeda Pharmaceutical Company Limited's market capitalisation today?
Takeda Pharmaceutical Company Limited market capitalisation is $0.04T as on .
How to invest in Takeda Pharmaceutical Company Limited Stock (TAK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Takeda Pharmaceutical Company Limited on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Takeda Pharmaceutical Company Limited Shares that will get you 0.1090 shares as per Takeda Pharmaceutical Company Limited share price of $13.76 per share as on October 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Takeda Pharmaceutical Company Limited Stock (TAK) from India?
Indian investors can start investing in Takeda Pharmaceutical Company Limited (TAK) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Takeda Pharmaceutical Company Limited stock (as per the Rupee-Dollar exchange rate as on ).
Based on Takeda Pharmaceutical Company Limited share’s latest price of $13.76 as on October 30, 2025 at 1:29 am IST, you will get 0.7267 shares of Takeda Pharmaceutical Company Limited. Learn more about
fractional shares .
What are the returns that Takeda Pharmaceutical Company Limited has given to Indian investors in the last 5 years?
Takeda Pharmaceutical Company Limited stock has given -11.6% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?